生体触媒および酵素工学市場規模、シェア、動向、地域別 – 2035年までの世界予測

生体触媒および酵素工学市場調査レポート – 製品タイプ（酵素、補酵素）、用途（医薬品製造、合成生物学・代謝工学、診断、その他）、エンドユーザー（製薬・バイオ医薬品企業、CRO・CDMO、診断・臨床検査機関、その他）、地域（北米、欧州、アジア太平洋、南米、中東・アフリカ）別 – 2035年までの世界予測

世界の生体触媒および酵素工学市場は、2025年に31億8,131万米ドルと評価され、2035年には56億3,187万米ドルに達すると予測されています。持続可能かつ効率的なバイオプロセス・ソリューションへの需要拡大を背景に、同市場は予測期間中に年平均成長率（CAGR）5.88%で拡大すると見込まれています。

Report Description

The Global Biocatalysts and Enzyme Engineering Market was valued at USD 3,181.31 million in 2025 and is projected to reach USD 5,631.87 million by 2035. The market is expected to expand at a CAGR of 5.88% during the forecast period, driven by increasing demand for sustainable and efficient bioprocessing solutions.

Growing Demand from the Pharmaceutical and Biopharmaceutical Industries Drives Market Growth

The expanding pharmaceutical and biopharmaceutical sectors are the primary drivers of the global biocatalysts and enzyme engineering market, as enzyme-based technologies enable the precise, efficient, and cost-effective production of complex drug molecules. Rising demand for biologics, gene therapies, and personalized medicines is further accelerating the adoption of advanced enzyme engineering solutions.

Market Segmentation Overview

By Product Type

• Enzymes: Widely used for efficient and precise biocatalytic reactions.
• Co-Enzyme: Supports enzyme activity in complex biochemical processes.

By Application

• Pharmaceutical Manufacturing: Enables cost-effective production of high-purity pharmaceutical compounds.
• Synthetic Biology and Metabolic Engineering: Facilitates engineered biological pathways for advanced bioprocesses.
• Diagnostic: Enhances accuracy and reliability of diagnostic testing methods.
• Others: Supports diverse industrial and research-based biological applications.

By End User

• Pharmaceutical and Biopharmaceutical Companies: Major adopters for innovative drug development processes.
• CROs and CDMOs: Offer specialized enzyme-based research and manufacturing services.
• Diagnostics and Clinical Laboratories: Utilize enzymes for accurate clinical testing applications.
• Others: Includes academic institutes and industrial research organizations.

Regional Analysis

North America and Europe lead the global biocatalysts and enzyme engineering market with strong research capabilities, established biotechnology industries, and advanced manufacturing infrastructure. Meanwhile, Asia Pacific is witnessing the fastest growth, while South America and the Middle East & Africa are steadily expanding through rising pharmaceutical investments and increasing adoption of sustainable bioprocessing technologies.

Strategic Collaboration for siRNA Manufacturing

March 2026 – CODEXIS: Codexis entered into a strategic agreement with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA (siRNA) using its proprietary ECO Synthesis platform. The collaboration supports preclinical development of a cardiovascular therapeutic candidate while reinforcing the company’s leadership in scalable enzymatic manufacturing solutions.

Strategic Edge: Strengthening Innovation Through Academic Partnerships

Collaborations between biocatalyst companies and universities are creating significant opportunities to accelerate enzyme discovery and next-generation biocatalyst development. By leveraging advanced research expertise, specialized facilities, and scientific innovation, companies can develop high-performance enzyme solutions while reducing research costs and time-to-market.

Key Report Attributes

• Market Size 2025: USD 3,181.31 Million
• Market Size 2035: USD 5,631.87 Million
• CAGR (2025-2035): 5.88%
• Base Year: 2024
• Market Forecast Period: 2025-2035

Industry Segmentations Growth

• By Product Type: Enzymes – 6.04%, Co- Enzyme – 5.10%.
• By Application: Pharmaceutical Manufacturing – 5.44%, Synthetic Biology and Metabolic Engineering – 7.15%.
• By End User: Pharmaceutical and Biopharmaceutical Companies – 5.44%, CROs and CDMOs – 7.15%.

Companies Mentioned

NovoZyme A/S, Codexis, Inc., Biocatalysts Ltd, Amano Enzyme Inc., Infinita, Advanced Enzyme Technologies Ltd., Asymchem Lab Group, Almac, Enginzyme, Creative Enzymes

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ……….. 17
2 MARKET INTRODUCTION …….. 19
2.1 DEFINITION …………………. 19
2.2 SCOPE OF THE STUDY …………………. 19
2.3 RESEARCH OBJECTIVE ……………….. 19
2.4 MARKET STRUCTURE …………………. 20
3 RESEARCH METHODOLOGY …………………. 21
3.1 OVERVIEW …. 21
3.2 DATA FLOW …………………. 23
3.2.1 DATA MINING PROCESS ……… 23
3.3 PURCHASED DATABASE: …………….. 24
3.4 SECONDARY SOURCES: ……………….. 25
3.4.1 SECONDARY RESEARCH DATA FLOW: ……… 26
3.5 PRIMARY RESEARCH: … 27
3.5.1 PRIMARY RESEARCH DATA FLOW: …………. 28
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED …………. 29
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ……….. 30
3.6.1 REVENUE ANALYSIS APPROACH …………….. 30
3.7 DATA FORECASTING….. 31
3.7.1 DATA FORECASTING TYPE …… 31
3.8 DATA MODELING ………… 32
3.8.1 MICROECONOMIC FACTOR ANALYSIS: …….. 32
3.8.2 DATA MODELING: ………………. 33
3.9 TEAMS AND ANALYST CONTRIBUTION ……. 35
4 MARKET DYNAMICS ……………. 37
4.1 MARKET TRENDS IN GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING ……………. 37
4.1.1 SHIFT TOWARD GREEN AND SUSTAINABLE CHEMISTRY …………………. 37
4.1.2 ADVANCEMENTS IN ENZYME ENGINEERING TECHNOLOGIES …………… 37
4.1.3 INCREASING USE IN PHARMACEUTICAL MANUFACTURING ……………… 37
4.2 DRIVERS ……… 38
4.2.1 INCREASING DEMAND FOR GREEN TECHNOLOGIES ……… 38
4.2.2 RISING HEALTHCARE COSTS …………………. 39
4.2.3 GROWING DEMAND FROM PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES …………………. 39
4.3 RESTRAINTS ……………….. 39
4.3.1 HIGH PRODUCTION COSTS ….. 39
4.3.2 REGULATORY CHALLENGES …. 40
4.3.3 ENZYME STABILITY AND OPERATIONAL LIMITATIONS …. 40
4.4 OPPORTUNITIES …………. 41
4.4.1 EXPANSION INTO EMERGING MARKETS …… 41
4.4.2 PARTNERSHIPS WITH ACADEMIC INSTITUTIONS …………. 41
5 MARKET FACTOR ANALYSIS …………………. 43
5.1 PESTLE ANALYSIS ……… 43
5.1.1 POLITICAL FACTORS ………….. 43
5.1.2 ECONOMIC FACTORS …………. 43
5.1.3 SOCIAL FACTORS ………………. 43
5.1.4 TECHNOLOGICAL FACTORS …. 44
5.1.5 LEGAL FACTOR …………………. 44
5.1.6 ENVIRONMENTAL FACTORS … 44
5.2 PORTER’S FIVE FORCES MODEL … 45
5.2.1 THREAT OF NEW ENTRANTS … 45
5.2.2 BARGAINING POWER OF SUPPLIERS ……….. 46
5.2.3 THREAT OF SUBSTITUTES …… 46
5.2.4 BARGAINING POWER OF BUYERS ……………. 46
5.2.5 INTENSITY OF RIVALRY ………. 47
5.3 REGULATORY ENVIRONMENT & COMPLIANCE …………. 47
5.3.1 OVERVIEW OF REGULATORY FRAMEWORK …………………. 47
5.3.2 PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS ……………… 47
5.4 TECHNOLOGICAL TRENDS ………….. 48
5.4.1 PROTEIN ENGINEERING AND DIRECTED EVOLUTION …….. 48
5.4.2 SYNTHETIC BIOLOGY AND PATHWAY ENGINEERING…….. 48
5.5 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS …………………. 48
5.6 PARTNERSHIPS & COLLABORATIONS ………… 49
5.6.1 ENZYME TECHNOLOGY ALLIANCE ADDS BIO-PRODICT …. 49
5.6.2 ACIES BIO AND PROTEIN EVOLUTION PARTNERSHIP ……. 49
5.6.3 AMINOVERSE AND PROZOMIX STRATEGIC COLLABORATION …………… 49
6 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE …………. 51
6.1 OVERVIEW …. 51
6.2 ENZYME ……… 53
6.2.1 KETOREDUCTASE ………………. 53
6.2.2 LACTATE DEHYDROGENASE … 53
6.2.3 FORMATE DEHYDROGENASE …………………. 53
6.2.4 GLUCOSE DEHYDROGENASE … 53
6.2.5 D-AMINO ACID DEHYDROGENASE …………… 53
6.2.6 NITRO REDUCTASE …………….. 54
6.2.7 MONOAMINE OXIDASE ……….. 54
6.2.8 NITRILASE ………. 54
6.2.9 AMIDASE ……….. 54
6.2.10 NITRILE REDUCTASE…………… 54
6.2.11 ALCOHOL OXIDASE ……………. 54
6.2.12 GALACTOSE OXIDASE …………. 54
6.2.13 Ω-TRANSAMINASES (ATA) …… 54
6.2.14 ALDOLASE ……… 55
6.2.15 PROTEASE ……… 55
6.2.16 LIPASE …………… 55
6.2.17 OTHERS …………. 55
6.3 CO-ENZYMES ………………. 55
6.3.1 NAD⁺ / NADH ….. 55
6.3.2 NADP⁺ / NADPH ………………… 56
6.3.3 NMN ……………… 56
6.3.4 FAD / FMN ……… 56
6.3.5 OTHERS …………. 56
7 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION …………….. 57
7.1 OVERVIEW …. 57
7.2 PHARMACEUTICALS MANUFACTURING ….. 58
7.3 SYNTHETIC BIOLOGY AND METABOLIC ENGINEERING ……………… 58
7.4 DIAGNOSTIC ………………… 59
7.5 OTHERS ………. 59
8 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER …………………. 61
8.1 OVERVIEW …. 61
8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES … 62
8.3 CROS AND CDMOS ………. 62
8.4 DIAGNOSTICS AND CLINICAL LABORATORIES …………… 63
8.5 OTHERS ………. 63
9 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY REGION ……. 65
9.1 OVERVIEW …. 65
9.2 NORTH AMERICA ……….. 66
9.2.1 US…………………. 70
9.2.2 CANADA ………… 73
9.3 EUROPE ………. 75
9.3.1 GERMANY ………. 79
9.3.2 FRANCE …………. 81
9.3.3 UK ………………… 83
9.3.4 ITALY …………….. 85
9.3.5 SPAIN ……………. 87
9.3.6 RUSSIA ………….. 88
9.3.7 REST OF EUROPE ……………….. 91
9.4 ASIA-PACIFIC ………………. 93
9.4.1 CHINA ……………. 97
9.4.2 INDIA …………….. 99
9.4.3 JAPAN …………… 101
9.4.4 SOUTH KOREA …. 103
9.4.5 MALAYSIA ……… 105
9.4.6 THAILAND ………. 107
9.4.7 INDONESIA ……… 109
9.4.8 REST OF ASIA-PACIFIC ……….. 111
9.5 LATIN AMERICA …………. 113
9.5.1 MEXICO …………. 117
9.5.2 BRAZIL …………… 119
9.5.3 ARGENTINA ……. 121
9.5.4 REST OF LATAM ………………… 123
9.6 MIDDLE EAST & AFRICA ……………… 125
9.6.1 GCC ………………. 129
9.6.2 SOUTH AFRICA … 131
9.6.3 REST OF MEA ….. 133
10 COMPETITIVE LANDSCAPE …. 136
10.1 INTRODUCTION …………… 136
10.2 MARKET SHARE ANALYSIS, 2025 ………………. 137
10.3 COMPETITOR DASHBOARD…………. 138
10.4 PUBLIC PLAYERS STOCK SUMMARY …………. 139
10.4.1 PUBLIC PLAYERS STOCK SUMMARY ……….. 139
10.4.2 PUBLIC PLAYERS STOCK SUMMARY ……….. 139
10.4.3 PUBLIC PLAYERS STOCK SUMMARY ……….. 139
10.4.4 PUBLIC PLAYERS STOCK SUMMARY ……….. 139
10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES ………… 140
10.5.1 EVALUATION …… 140
11 COMPANY PROFILES ………….. 141
11.1 NOVONESIS … 141
11.1.1 COMPANY OVERVIEW ………… 141
11.1.2 FINANCIAL OVERVIEW ………… 142
11.1.3 PRODUCTS OFFERED ………….. 142
11.1.4 KEY DEVELOPMENTS ………….. 143
11.1.5 SWOT ANALYSIS ……………….. 144
11.1.6 KEY STRATEGIES ……………….. 144
11.2 CODEXIS, INC. ………………. 145
11.2.1 COMPANY OVERVIEW ………… 145
11.2.2 FINANCIAL OVERVIEW ………… 146
11.2.3 PRODUCTS OFFERED ………….. 147
11.2.4 KEY DEVELOPMENTS ………….. 147
11.2.5 KEY STRATEGIES ……………….. 147
11.3 BIOCATALYSTS LTD …… 149
11.3.1 COMPANY OVERVIEW …………. 149
11.3.2 FINANCIAL OVERVIEW ………… 150
11.3.3 PRODUCTS OFFERED ………….. 150
11.3.4 KEY DEVELOPMENTS ………….. 150
11.3.5 SWOT ANALYSIS ……………….. 151
11.3.6 KEY STRATEGIES ……………….. 151
11.4 AMANO ENZYME INC. …………………. 153
11.4.1 COMPANY OVERVIEW …………. 153
11.4.2 FINANCIAL OVERVIEW ………… 154
11.4.3 PRODUCTS OFFERED ………….. 154
11.4.4 SWOT ANALYSIS ……………….. 155
11.4.5 KEY DEVELOPMENTS ………….. 155
11.4.6 KEY STRATEGY … 155
11.5 INFINITA ……. 157
11.5.1 COMPANY OVERVIEW ………… 157
11.5.2 FINANCIAL OVERVIEW ………… 157
11.5.3 PRODUCTS OFFERED ………….. 157
11.5.4 KEY DEVELOPMENTS ………….. 159
11.5.5 KEY STRATEGIES ……………….. 159
11.6 ADVANCED ENZYMES …………………. 160
11.6.2 FINANCIAL OVERVIEW ………… 160
11.6.4 KEY DEVELOPMENTS ………….. 162
11.6.5 SWOT ANALYSIS ……………….. 162
11.7 CREATIVE ENZYMES …. 164
11.7.1 COMPANY OVERVIEW …………. 164
11.7.2 FINANCIAL OVERVIEW ………… 164
11.7.3 PRODUCTS OFFERED ………….. 165
11.7.4 KEY DEVELOPMENTS ………….. 165
11.7.5 SWOT ANALYSIS ……………….. 165
11.7.6 KEY STRATEGIES ……………….. 166
11.8 ASYMCHEM…………………. 167
11.8.1 COMPANY OVERVIEW …………. 167
11.8.2 FINANCIAL OVERVIEW ………… 168
11.8.3 PRODUCTS OFFERED ………….. 169
11.8.4 SWOT ANALYSIS ……………….. 169
11.8.5 KEY STRATEGIES ……………….. 169
11.9 ALMAC ……….. 171
11.9.2 FINANCIAL OVERVIEW ………… 172
11.9.4 KEY DEVELOPMENTS ………….. 173
11.9.5 SWOT ANALYSIS ……………….. 174
11.10 ENGINZYME ………………… 175
11.10.1 COMPANY OVERVIEW …………. 175
11.10.2 PRODUCTS OFFERED ………….. 176
11.10.3 KEY DEVELOPMENTS ………….. 176
11.10.4 KEY STRATEGIES ……………….. 176
12 DATA CITATIONS ………………… 178

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 34
TABLE 2 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 52
TABLE 3 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 57
TABLE 4 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019–2035 (USD MILLION) 62
TABLE 5 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY REGION, 2019-2035 (USD MILLION) 65
TABLE 6 NORTH AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 67
TABLE 7 NORTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 68
TABLE 8 NORTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 69
TABLE 9 NORTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 70
TABLE 10 US: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 70
TABLE 11 US: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 71
TABLE 12 US: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 72
TABLE 13 CANADA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 73
TABLE 14 CANADA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 74
TABLE 15 CANADA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 74
TABLE 16 EUROPE BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 76
TABLE 17 EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 77
TABLE 18 EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 78
TABLE 19 EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 79
TABLE 20 GERMANY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 79
TABLE 21 GERMANY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 80
TABLE 22 GERMANY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 81
TABLE 23 FRANCE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 81
TABLE 24 FRANCE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 82
TABLE 25 FRANCE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 82
TABLE 26 UK: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 83
TABLE 27 UK: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 84
TABLE 28 UK: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 84
TABLE 29 ITALY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 85
TABLE 30 ITALY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 86
TABLE 31 ITALY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 86
TABLE 32 SPAIN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 87
TABLE 33 SPAIN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 88
TABLE 34 SPAIN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 88
TABLE 35 RUSSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 89
TABLE 36 RUSSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 90
TABLE 37 RUSSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 90
TABLE 38 REST OF EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 91
TABLE 39 REST OF EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 92
TABLE 40 REST OF EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 92
TABLE 41 ASIA-PACIFIC BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 94
TABLE 42 ASIA PACIFIC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 95
TABLE 43 ASIA PACIFIC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 96
TABLE 44 ASIA PACIFIC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 96
TABLE 45 CHINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 97
TABLE 46 CHINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 98
TABLE 47 CHINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 98
TABLE 48 INDIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 99
TABLE 49 INDIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 100
TABLE 50 INDIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 100
TABLE 51 JAPAN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 101
TABLE 52 JAPAN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 102
TABLE 53 JAPAN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 102
TABLE 54 SOUTH KOREA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 103
TABLE 55 SOUTH KOREA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 104
TABLE 56 SOUTH KOREA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 104
TABLE 57 MALAYSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 105
TABLE 58 MALAYSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 106
TABLE 59 MALAYSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 106
TABLE 60 THAILAND: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 107
TABLE 61 THAILAND: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 108
TABLE 62 THAILAND: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 108
TABLE 63 INDONESIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 109
TABLE 64 INDONESIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 110
TABLE 65 INDONESIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 110
TABLE 66 REST OF APAC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 111
TABLE 67 REST OF APAC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 112
TABLE 68 REST OF APAC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 113
TABLE 69 LATIN AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 114
TABLE 70 SOUTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 115
TABLE 71 SOUTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 116
TABLE 72 SOUTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 116
TABLE 73 MEXICO: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 117
TABLE 74 MEXICO: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 118
TABLE 75 MEXICO: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 118
TABLE 76 BRAZIL: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 119
TABLE 77 BRAZIL: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 120
TABLE 78 BRAZIL: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 120
TABLE 79 ARGENTINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 121
TABLE 80 ARGENTINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 122
TABLE 81 ARGENTINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 122
TABLE 82 REST OF LATAM: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 123
TABLE 83 REST OF LATAM: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 124
TABLE 84 REST OF LATAM: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 124
TABLE 85 MIDDLE EAST & AFRICA BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 126
TABLE 86 MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 127
TABLE 87 MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 128
TABLE 88 MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 128
TABLE 89 GCC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 129
TABLE 90 GCC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 130
TABLE 91 GCC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 130
TABLE 92 SOUTH AFRICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 131
TABLE 93 SOUTH AFRICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 132
TABLE 94 SOUTH AFRICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 132
TABLE 95 REST OF MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 133
TABLE 96 REST OF MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 134
TABLE 97 REST OF MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 134
TABLE 98 EVALUATION 140
TABLE 99 NOVONESIS: PRODUCTS OFFERED 142
TABLE 100 CODEXIS INC.: PRODUCT OFFERED 147
TABLE 101 BIOCATALYSTS: PRODUCT OFFERED 150
TABLE 102 AMANO ENZYME INC.: PRODUCTS OFFERED 154
TABLE 103 INFINITA: PRODUCTS OFFERED 157
TABLE 105 CREATIVE ENZYMES: PRODUCTS OFFERED 165
TABLE 106 ASYMCHEM: PRODUCTS OFFERED 169
TABLE 108 ENGINZYME: PRODUCTS OFFERED 176

LIST OF FIGURES

FIGURE 1 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET: STRUCTURE
FIGURE 2 GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035) 38
FIGURE 3 PORTER’S FIVE FORCES ANALYSIS: GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET
FIGURE 4 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY TYPE, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 5 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY PRODUCT TYPE, 2025
FIGURE 6 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, ATTRACTIVENESS ANALYSIS
FIGURE 7 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY APPLICATION, 2024
FIGURE 8 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, ATTRACTIVENESS ANALYSIS
FIGURE 9 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY END USER, 2024
FIGURE 10 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY REGION, 2025
FIGURE 11 NORTH AMERICA MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 12 NORTH AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2025
FIGURE 13 EUROPE MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 14 EUROPE BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2025
FIGURE 15 ASIA-PACIFIC MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 16 ASIA-PACIFIC BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 17 LATIN AMERICA MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 18 LATIN AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 19 MIDDLE EAST & AFRICA MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 21 GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024
FIGURE 22 COMPETITOR DASHBOARD: GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET
FIGURE 23 NOVONESIS: SWOT ANALYSIS
FIGURE 24 BIOCATALYSTS LTD.: SWOT ANALYSIS
FIGURE 25 AMANO ENZYME INC.: SWOT ANALYSIS
FIGURE 26 ADVANCED ENZYMES: SWOT ANALYSIS
FIGURE 27 CREATIVE ENZYMES: SWOT ANALYSIS
FIGURE 28 ASYMCHEM: SWOT ANALYSIS
FIGURE 29 ALMAC: SWOT ANALYSIS

---

---